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Abstract
Antibody affinity maturation occurs in germinal centres (GC) where B cells cycle between the 
light zone (LZ) and the dark zone. In the LZ GC B cells bearing immunoglobulins with the highest 
affinity for antigen receive positive selection signals from T helper cells that promotes their rapid 
proliferation. Here we show that the RNA binding protein PTBP1 is necessary for the progression 
of GC B cells through late S-phase of the cell cycle and for affinity maturation. PTBP1 is required 
for the proper expression of the c-MYC-dependent gene program induced in GC B cells receiving 
T cell help and directly regulates the alternative splicing and abundance of transcripts increased 
during positive selection to promote proliferation.
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Introduction
Germinal centres (GCs) are specialized areas of secondary lymphoid tissues where B cells 
undergo antibody affinity maturation. The GC can be divided into a dark zone (DZ) 
characterized by extensive proliferation and somatic hypermutation (SHM) and a light zone 
(LZ) where B cells are less proliferative and make contacts with follicular dendritic cells and 
T cells. There, B cells are positively selected to survive and undergo further rounds of 
proliferation in the DZ1,2. T cell help promotes faster cell cycle progression, a greater 
number of cell divisions and increased SHM frequency resulting in increased antibody 
affinity maturation3,4. Positive selection in the LZ results in the transient expression of the 
transcription factor c-MYC necessary for the progression of selected cells through the cell 
cycle5,6. c-MYC also induces the transcription of genes important for anabolic 
metabolism3,7. Moreover, mTORC1 activity is increased during positive selection and 
promotes the anabolic gene expression program8. In addition to c-MYC, the transcription 
factors AP4, FOXO1 and BATF are important during the LZ-DZ transition of GC B cells9–
11. These findings highlight the existence in B cells of relays of transcription factors that are 
responsive to T cell help and promote B cell proliferation and mutation.
Alternative splicing (AS), alternative polyadenylation (APA), mRNA decay and translation 
have the potential to regulate cell fate. However, we know relatively little about the relevant 
changes and regulation of AS during immune responses12–15 and molecular regulation of 
APA is only beginning to be appreciated16,17. The impact of RNA binding proteins (RBP) 
that have the potential to integrate multiple aspects of gene expression in B cells undergoing 
selection in the GC is only emerging13,14.
One class of RBP with pleiotropic function are the Polypyrimidine Tract Binding Proteins 
(PTBP)18–20. Most cell types express PTBP1, whereas PTBP2 is abundant in differentiated 
neurons. During neuronal differentiation there is a switch between the expression of PTBP1 
and PTBP2 which drives changes in AS patterns of genes important for neuronal 
function18,21. PTBP3 is highly expressed in hematopoietic cells and previously shown to be 
co-expressed with PTBP1 in B lymphocytes22. PTBP1 is both a repressor and an activator 
of AS18 and has been implicated in APA, mRNA decay and translational 
regulation19,23,24. In CD4 T cells PTBP1 has been shown to enhance CD40L-mRNA 
stability25 and in human B cells to be responsive to toll-like receptor 926. Although PTBP1 
has the potential to regulate posttranscriptional gene expression programs in lymphocytes its 
physiological functions in lymphocyte development and activation are unknown.
Here we show that PTBP1 acts in concert with c-MYC to ensure the selection of B cell 
clones with the highest affinity for antigen by promoting the proliferation of GC B cells. 
PTBP1 guarantees proper posttranscriptional processing and expression of genes induced as 
part of the c-MYC-dependent gene expression program.
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Results
PTBP1 expression is increased in positively selected GC B cells
Uniquely amongst Ptb-family members the expression of Ptbp1-mRNA was increased ~1.5-
fold in GC B cells compared to naive B cells (Supplementary Fig. 1a,b). Ptbp2 transcripts 
were rare and showed evidence of skipping exon 10 (Supplementary Fig. 1b) generating 
mRNAs degraded by nonsense-mediated RNA decay (NMD)27. Ptbp1- but not Ptbp3-
mRNA was increased 1.4-fold upon c-MYC expression in LZ B cells (Fig. 1a) and was also 
increased in GC B cells that had received the greatest levels of T cell help (Supplementary 
Fig. 1c,d). A validated a panel of monoclonal antibodies recognizing PTBP1, PTBP2 and 
PTBP3 that were specific for each PTBP and able to detect the proteins by flow cytometry 
(Supplementary Fig. 2a,b) detected PTBP1 and PTBP3 but not PTBP2 in B cells (Fig. 1b, 
Supplementary Fig. 1f and 2a,b). PTBP1 protein was increased (~1.6-fold) in GC B cells 
compared to non-GC B cells (Fig. 1b) and increased ~1.4-fold in GFP-c-MYC reporter 
transgene (MycGFP)-positive GC B cells compared to GFP-c-MYC-negative GC B cells 
(Fig. 1c). Previous studies showed that PTBP1 expression correlates positively with c-
MYC28 and that c-MYC binds to the promoter of PTBP1 in B cells29. Thus PTBP1 may act 
downstream of, or in parallel with c-MYC, in GC B cells responding to T cell help.
PTBP1 is dispensable for B cell development
We validated conditional knockout (cKO) mice targeting Ptbp130 from the pro-B cell stage 
by using the Cd79acre allele (Supplementary Fig. 2b,c,d). B cell development was normal in 
the absence of PTBP1 (Supplementary Fig. 2c,e,f). Moreover, in lethally-irradiated CD45.1+ 
B6.SJL mice reconstituted with a 1:1 mixture of bone marrow cells from B6.SJL and 
Cd79acre/+Ptbp1fl/fl mice the numbers of follicular B cells arising from the 
Cd79acre/+Ptbp1fl/fl cKO bone marrow were not reduced compared to those arising from 
B6.SJL bone marrow (Data not shown). In cells that had deleted Ptbp1 the expression of 
PTBP2 was evident from the pro-B cell stage onwards (Supplementary Fig. 2d). The loss of 
PTBP1 and expression of PTBP2 was confirmed by immuno-blotting (Supplementary Fig. 
2a). As expected31, Ptbp1-deficient B cells also contained increased amounts of the long-
isoform of PTBP3 (Supplementary Fig. 2a). This indicates that although PTBP1 is not 
necessary for B cell development its deletion is consequential at the molecular level.
PTBP1 in B cells is necessary for the GC B cell response
We immunised Cd79acre/+Ptbp1fl/fl and Cd79a+/+Ptbp1fl/fl mice with 4-hydroxy-3-
nitrophenyl-acetyl conjugated to keyhole limpet hemocyanin (NP-KLH). Seven days later 
the proportions and absolute numbers of GC B cells per spleen were reduced (5.9- and 3.9-
fold, respectively) in Cd79acre/+Ptbp1fl/fl cKO compared to Cd79a+/+Ptbp1fl/fl control mice 
(Fig. 2a,b). The proportions of GC B cells with a DZ phenotype were reduced in Ptbp1-
deficient GC B cells compared to control GC B cells (Fig. 2a,b) despite efficient depletion of 
the protein (Supplementary Fig. 3a). By contrast, Cd79acre/+Ptbp1fl/+ mice immunised with 
NP-KLH showed similar GC B cell responses to those of Cd79a+/+Ptbp1fl/fl mice 
(Supplementary Fig. 3b,c). The same GC B cell defects were found in Cd79acre/+Ptbp1fl/fl 
cKO GC B cells from bone marrow chimeras where B6.SJL mice were reconstituted with a 
1:1 mixture of bone marrow cells from CD45.1+ B6.SJL and CD45.2+ Cd79acre/+Ptbp1fl/fl 
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cKO mice (Supplementary Fig. 3d,e). Therefore, the defect in Ptbp1-deficient GC B cells 
was cell-autonomous. These data indicate an indispensable role for PTBP1 function in GC B 
cells.
PTBP1 is necessary for antibody affinity maturation
Cd79acre/+Ptbp1fl/fl cKO mice produced reduced amounts of high affinity antibodies 
compared to Cd79a+/+Ptbp1fl/fl control mice (Fig. 2c). In Cd79a+/+Ptbp1fl/fl control mice the 
ratio of high affinity versus total affinity antibodies increased over time, but this ratio 
remained low in Cd79acre/+Ptbp1fl/fl cKO mice (Fig. 2d). Antibodies from mice lacking 
Ptbp2 in B cells (Cd79acre/+Ptbp2fl/fl) showed no defect in affinity maturation compared to 
Cd79a+/+Ptbp2fl/fl mice (Supplementary Fig. 3f,g). Cd79acre/+Ptbp1fl/fl cKO GC B cells had 
switched to IgG1 in vivo at greater frequencies compared to Cd79a+/+Ptbp1fl/fl control GC B 
cells (Supplementary Fig. 3h), indicating the presence of functional AID in Ptbp1-deficient 
GC B cells. Additionally, mutations were found at similar frequencies in the Jh4-intronic 
region of GC B cells sorted from Cd79acre/+Ptbp1fl/fl and Cd79a+/+Ptbp1fl/fl mice 
(Supplementary Fig. 3i,j). Thus, PTBP1 is necessary in B cells for optimal antibody affinity 
maturation, but this is unlikely to stem from reduced function of AID.
PTBP2 partially compensates for the loss of PTBP1 in GC B cells
The expression of PTBP2 in Ptbp1-deficient GC B cells could compensate for the absence of 
PTBP1 in GC cells31,32. To address this in the absence of confounding effects due to the 
deletion of genes during the bone marrow stages of B cell development, we introduced 
transgenic-Aicda-cre (AicdaTg-cre) to generate Ptbp1 single and Ptbp1:Ptbp2 double 
conditional knockout (dcKO) mice. After immunisation with sheep red blood cells (SRBCs) 
the numbers and proportions of GC B cells of AicdaTg-cre Ptbp1fl/fl cKO mice were 
reduced compared to Ptbp1fl/flPtbp2fl/fl control mice and the remaining GC B cells had the 
altered LZ/DZ phenotype seen in Cd79acre/+Ptbp1fl/fl mice (Fig. 3a,b). AicdaTg-cre 
Ptbp1+/+Ptbp2+/+ mice showed similar LZ and DZ B cell numbers compared to 
Ptbp1fl/flPtbp2fl/fl control mice (Supplementary Fig. 3k). Thus, PTBP1 function in B cells is 
required subsequent to B cell activation and expression of AID.
Compared to Ptbp1fl/flPtbp2fl/fl control and AicdaTg-cre Ptbp1fl/fl single cKO mice very few 
GC B cells were detected in AicdaTg-cre Ptbp1fl/flPtbp2fl/fl dcKO mice (Fig. 3a,b and 
Supplementary Fig. 3k). The residual AicdaTg-cre Ptbp1fl/flPtbp2fl/fl dcKO GC B cells had 
the phenotype typical of LZ B cells (Fig. 3a,b) and they expressed PTBP3, reduced amounts 
of PTBP1 but no PTBP2 (Fig. 3c,d). No NP-specific IgG1 antibody secreting cells were 
detected in AicdaTg-cre Ptbp1fl/flPtbp2fl/fl dcKO mice 21 days after immunisation with NP-
KLH (Data not shown). Thus, PTBP2, but not PTBP3, partially compensates for the loss of 
PTBP1.
PTBP1 regulates mRNA abundance and alternative splicing in GC B cells
We performed mRNAseq on LZ and DZ B cells of Cd79a+/+Ptbp1fl/fl control and 
Cd79acre/+Ptbp1fl/fl cKO (PTBP1 cKO) mice. In addition, we generated a transcriptome-
wide inventory of PTBP1 binding sites in mitogen-activated B cells using individual-
nucleotide resolution Cross-Linking and ImmunoPrecipitation (iCLIP) (Supplementary 
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Table 1). By combining mRNAseq with PTBP1 iCLIP we can discern direct from indirect 
effects of PTBP1 on the transcriptome and, through the consideration of positional 
information, deduce the likely mechanism of action of PTBP1. Changes in mRNA 
abundance at the whole gene level in control LZ B cells compared to control DZ B cells 
were consistent with those seen previously33 and were conserved in Ptbp1-deficient GC B 
cells (Fig. 4a, Supplementary Fig. 4a,b and Supplementary Table 2).
Comparison of PTBP1 cKO to control GC B cells revealed 998 and 980 genes with 
increased and decreased mRNA abundance, respectively, in the LZ, and 409 and 270 genes 
with increased and decreased mRNA abundance, respectively, in the DZ (Fig. 4b, 
Supplementary Table 2). The changes in genes that were differentially expressed in LZ and 
DZ B cells due to Ptbp1 deletion showed a strong positive correlation (Supplementary Fig. 
4c) indicating that the absence of PTBP1 affects the same genes in LZ and DZ B cells. 
PTBP1 can increase mRNA stability when bound to 3’UTRs19,23. Amongst genes with 
either increased or decreased mRNA abundance the proportions of genes bound by PTBP1 
in their 3’UTRs were similar (~20%, Supplementary Fig. 4d). Thus, PTBP1-binding to 
3’UTRs does not appear to have a marked preference towards increasing or decreasing 
mRNA stability in GC B cells.
We used rMATS to determine inclusion level differences between two conditions for five 
different types of AS events (Supplementary Fig. 4e,f). We identified 266 AS events more 
skipped and 316 events more included (from 506 genes) with an inclusion level difference 
greater than 10% in control LZ compared to control DZ B cells (Fig. 4c, Supplementary 
Table 3) indicating extensive AS changes in the transition between LZ and DZ. The changes 
in AS due to Ptbp1 deficiency were greater in both the magnitude and the number of events 
(Fig. 4d, 856 AS events in LZ and 960 AS events in DZ GC B cells) than the changes seen 
between LZ and DZ control B cells (Fig. 4c, 582 events). The 52% overlap of AS events that 
change between LZ and DZ in control B cells and those affected by Ptbp1 deletion 
(Supplementary Fig. 4g) indicates that PTBP1 affects a substantial proportion of the AS 
events that differ between LZ and DZ B cells.
In LZ B cells 379 AS events were more skipped and 477 AS events were more included (in 
670 genes) due to Ptbp1 deletion (Fig. 4d, Supplementary Table 3). In DZ B cells, 416 AS 
events were more skipped and 544 AS events were more included (in 747 genes) due to 
Ptbp1 deletion (Fig. 4d, Supplementary Table 3). The proportions of AS events directly 
regulated by PTBP1, inferred from the binding of PTBP1 in the vicinity of the event, varied 
depending on the type of AS event and ranged from ~50% in mutually exclusive exons 
(MXEs) to ~7% in alternative 3’ splice sites (A3SS) (Supplementary Fig. 4h). The 
proportions of skipped and included AS events due to Ptbp1 deletion bound by PTBP1 were 
similar (Supplementary Fig. 4h) indicating that PTBP1 both represses and activates AS in 
GC B cells. The overlap between genes that have different mRNA abundance and those that 
have different AS due to Ptbp1 deletion is 6% in LZ and in 8% DZ (Fig. 4e). Similarly, there 
was a small overlap between genes with changes in abundance and AS when control LZ B 
cells are compared to control DZ B cells (Fig. 4e). Taken together, our data shows that 
PTBP1 is a posttranscriptional regulator in GC B cells where it controls mRNA abundance 
and five different types of AS events.
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PTBP1 is necessary for the c-MYC-dependent program induced upon positive selection
To determine if PTBP1 regulated changes in annotated gene ontology (GO) pathways we 
examined genes with changes at the mRNA abundance or AS level separately. Several GO 
terms relevant to the biology of GC B cells were enriched amongst genes with different 
mRNA abundance (Supplementary Fig. 5 and Supplementary Table 4). No pathways were 
enriched (FDR<0.1) when AS changes were analysed (Supplementary Table 4). Instead, 
individual genes of different pathways are regulated by PTBP1 at the AS level.
Pathways involved in nucleotide biosynthesis and cell proliferation were enriched amongst 
genes with differential mRNA abundance in LZ and DZ B cells (Supplementary Fig. 5a-c). 
In LZ B cells most of the differentially expressed genes within these pathways had 
decreased mRNA abundance (Supplementary Fig. 5b). Genes involved in the regulation of 
Ras protein signaling were also enriched in LZ B cells, but most of these genes had 
increased mRNA abundance (Supplementary Fig. 5b). Pathways implicated in B cell 
differentiation, lymphocyte migration, cholesterol metabolism and the regulation of 
apoptosis in leukocytes were enriched in DZ B cells (Supplementary Fig. 5a,c). Among the 
243 genes with different mRNA abundance that belong to the enriched pathways we found 
64 bound by PTBP1 in their 3’UTR and only 10 to be AS in the absence of PTBP1 
(Supplementary Fig. 5b,c). Thus PTBP1 directly regulates some of these genes, but also has 
an indirect effect on the expression of genes in these pathways. We investigated further how 
the lack of PTBP1 affects the expression of genes that are part of the c-MYC hallmark34 
and also of genes induced in response to T cell help3,7. In LZ B cells lacking PTBP1 there 
was a global decrease in mRNA abundance of the genes induced upon positive selection 
compared to control LZ B cells (Fig. 5a). 21% of the genes with reduced mRNA abundance 
in LZ B cells due to Ptbp1 deletion are part of the gene expression program induced upon 
positive selection (Supplementary Fig. 6a and Supplementary Table 5).
Myc mRNA abundance and AS pattern were the same in Cd79acre/+Ptbp1fl/fl cKO and 
Cd79a+/+Ptbp1fl/fl control LZ B cells (Fig. 5b and Supplementary Table 3). The proportions 
of GFP-cMYC+ GC B cells and c-MYC protein levels following SRBC immunisation in 
Rag2-/- mice reconstituted with Cd79acre/+Ptbp1fl/flMycGFP/GFP bone marrow cells were 
similar to those of Rag2–/– mice reconstituted with Cd79a+/+Ptbp1fl/flMycGFP/GFP bone 
marrow cells (Fig. 5c,d). Furthermore, Tfap4 mRNA encoding AP4 (Fig. 5b) and the levels 
of Ser240/244 phosphorylation of ribosomal protein S6 in Cd79acre/+Ptbp1fl/fl cKO LZ GC 
B cells were similar to those of Cd79a+/+Ptbp1fl/fl control LZ GC B cells (Supplementary 
Fig. 6b). Additionally, Cxcr4, Cxcr5, Bcl-6, Bach2, Aicda, IL21r, Foxo1 and Batf and had 
equivalent expression and AS patterns in Ptbp1-deficient and control GC B cells 
(Supplementary Fig. 6c-e and Supplementary Table 3). Thus GC B cells do not require 
PTBP1 for the sensing of T cell help or the induced expression of c-MYC.
28% of the mRNAs that are part of the c-MYC-dependent gene expression program induced 
upon positive selection and reduced in LZ B cells due to Ptbp1 deletion were bound by 
PTBP1 in their 3’UTR (Supplementary Fig. 6a and Supplementary Table 5). This indicates a 
direct role of PTBP1 in stabilising a fraction, but not all, of c-MYC-dependent transcripts. 
Moreover, 22 genes induced upon positive selection showed differential AS (inclusion level 
difference >10%) due to Ptbp1-deletion (Fig. 5e and Supplementary Fig. 6a) and six of these 
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were bound by PTBP1 near the AS event (Supplementary Table 5). Pkm, Abcb1b, Tspan33, 
Phb2 and Dkc1 were the only genes with both reduced mRNA abundance and also 
differential AS (inclusion level difference >10%) due to the lack of PTBP1. Thus PTBP1 
regulates directly and indirectly the expression of the c-MYC-dependent gene expression 
program in positively selected GC B cells through regulating mRNA abundance and AS.
PTBP1 regulates proliferation of GC B cells
We analysed if PTBP1 was required for GC B cell proliferation by measuring DNA content 
and the incorporation of bromodeoxyuridine (BrdU) into GC B cells in vivo. The 
proportions of Cd79acre/+Ptbp1fl/fl cKO GC B cells in late S-phase (BrdU+ with high DNA 
content) were reduced compared to control Cd79a+/+Ptbp1fl/fl GC B cells in mice 
immunised with NP-KLH (Fig. 6a,b). By contrast, the proportions of cells that were in early 
S-phase (BrdU+ with low DNA content) were similar between Cd79acre/+Ptbp1fl/fl cKO and 
control Cd79+/+Ptbp1fl/fl GC B cells. Additionally, Cd79acre/+Ptbp1fl/fl cKO GC B cells had 
increased proportions of cells in G2/M phases compared to control Cd79a+/+Ptbp1fl/fl GC B 
cells (Fig. 6a,b). The proportions of cells in late S-phase were reduced in both LZ (5/5 
experiments) and DZ (4/5 experiments) B cells from Cd79acre/+Ptbp1fl/fl cKO mice 
compared to Cd79a+/+Ptbp1fl/fl controls (Supplementary Fig. 7a). We also observed a 
reduction in the proportion of cells in late S-phase of GC B cells from AicdaTg-cre Ptbp1fl/fl 
cKOs compared to AicdaTg-cre Ptbp1+/+Ptbp2+/+ or Ptbp1fl/flPtbp2fl/fl controls immunised 
with SRBCs (Supplementary Fig. 7b). The proportions of GC B cells in late S-phase were 
also reduced amongst Ptbp1-deficient cells in bone marrow chimeras immunised with NP-
KLH (Supplementary Fig. 7c) showing that this is a cell autonomous defect. In contrast to 
GC B cells, the proportions of cells at different stages of the cell cycle were normal in the 
highly proliferative early-pre B cells of Cd79acre/+Ptbp1fl/fl cKO mice (Supplementary Fig. 
7d). Thus PTBP1 is not universally required in cells that are undergoing cell division but is 
necessary for the progression of GC B cells through late S-phase.
Closer examination of the expression of genes important for cell cycle progression revealed 
that Ccnd2, Ccnd3 and Ccne2 were unaffected in Cd79acre/+Ptbp1fl/fl cKO GC B cells 
compared to Cd79a+/+Ptbp1fl/fl control GC B cells (Supplementary Fig. 7e) suggesting that 
the GO enrichment in proliferation and nucleotide biosynthetic pathways does not arise from 
a failure to express early cell cycle progression factors. Impaired nucleotide synthesis could 
cause replication stress as cells progress through S-phase and cause cell death35. Flow 
cytometric analyses using a fixable viability dye to detect non-viable cells showed a higher 
proportion of dead cells amongst Cd79acre/+Ptbp1fl/fl compared to Cd79a+/+Ptbp1fl/fl DZ GC 
B cells (Fig. 6c,d). By contrast, the proportions of dead cells in LZ B cells were similar 
between Ptbp1-deficient and sufficient cells (Fig. 6c,d). PTBP1 is thus necessary for 
progression through the S and G2/M phases of the cell cycle and promotes the survival of 
DZ cells.
PTBP1 controls alternative splicing of c-Myc target genes that regulate B cell proliferation
Given the impaired proliferation of Ptbp1-deficient GC B cells we looked for evidence of 
PTBP1-dependent AS isoforms amongst genes that are part of the c-MYC-dependent gene 
expression program that are important for proliferation. The mRNA encoding thymidylate 
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synthase (Tyms), a c-MYC target gene (Fig. 5a) necessary for de novo nucleotide synthesis, 
is 30-fold increased in GC B cells compared to naive B cells and is increased upon positive 
selection in GC B cells (Fig. 7a). Tyms mRNA was differentially spliced in the absence of 
PTBP1 (Fig. 7b). Ptbp1 deletion resulted in a complex AS pattern with increased inclusion 
of exons and retained introns (yellow bins, Fig. 7b) that generate NMD-predicted transcript 
isoforms. We quantified the ratio of mRNAseq reads that map to segments generating NMD-
predicted transcripts (NMD yellow bins, Fig. 7b) relative to mRNAseq reads that map to the 
first three exons of Tyms which encode the full-length protein (FL blue bins, Fig. 7b). The 
ratio of NMD/FL reads was reduced upon positive selection in GC B cells indicating an 
increase of protein coding Tyms mRNA in positively selected GC B cells (Fig. 7c). The 
NMD/FL read ratio was increased in LZ and DZ B cells (Fig. 7d) and Tyms mRNA 
abundance (at the whole gene level) was reduced due to Ptbp1 deletion in LZ B cells (Fig. 
7e). TYMS protein was reduced due to Ptbp1 deletion in LZ and DZ B cells (Fig. 7f). 
Consistent with a direct role for PTBP1 in regulating these Tyms AS events, iCLIP showed 
PTBP1 bound to this region (Fig. 7a). These data indicate that PTBP1 ensures increased 
TYMS expression during positive selection by regulating Tyms AS.
M-type pyruvate kinase (Pkm) catalyses the conversion of phosphoenolpyruvate to pyruvate 
in glycolysis and is also a c-Myc target28 that is differentially spliced due to Ptbp1 deletion 
(Fig. 5e). Pkm encodes two protein isoforms generated from mutually exclusive inclusion of 
exon 9 (PKM1) or exon 10 (PKM2). Whereas PKM1 exists only as a highly active 
tetrameric form, PKM2 interchanges between less active monomeric and dimeric forms as 
well as a fully active tetramer in response to nutrient availability and energy demands36. B 
cells express Pkm2 almost exclusively and Pkm2, but not Pkm1, is induced upon positive 
selection in GC B cells (Fig. 8a). In the absence of PTBP1 the inclusion level of exon 9 is 
increased from 0.05 to 0.2 (Fig. 8b,c). Immunoblot of proteins from naive and mitogen-
activated B cells in vitro revealed that PKM1 was hardly detected in Cd79a+/+Ptbp1fl/fl B 
cells but readily detected in Cd79acre/+Ptbp1fl/fl cKO B cells (Fig. 8d). This AS event has 
been previously shown to be regulated by PTBP1 in human cell lines to favour the 
production of PKM228,31. Our iCLIP data revealed PTBP1 binding close to the intronic 3’ 
splice site of exon 9 in B cells (Fig. 8c). Thus, PTBP1 promotes skipping of this exon 
favouring inclusion of exon 10 and suppression of Pkm1 mRNA in GC B cells (Fig. 8e).
Expression of PKM1 has been shown to impair the proliferation of malignant cells and non-
transformed fibroblasts and the small molecule DASA-58 activates PKM2 tetramerization 
and inhibits the proliferation of transformed cells36. DASA-58 reduced the proliferation of 
mouse B cells in response to in vitro stimulation with anti-CD40+IL-4+IL-5 or anti-IgM
+IL-4 (Fig. 8f,g). These findings are consistent with the hypothesis that increased activity of 
pyruvate kinase, as would be expected upon PKM1 expression, is detrimental for B cell 
proliferation.
Discussion
PTBP1 is either induced by and acts downstream of c-MYC, or forms part of a previously 
unrecognised pathway that acts in parallel with c-MYC to drive GC B cell proliferation. We 
favour the former hypothesis as there is evidence that PTBP1 is a c-MYC-responsive gene in 
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other cell systems28,29. A proliferation defect of Ptbp1-deficient ES cells and human CD4 
T cells with reduced PTBP1 levels has been observed30,37,38 indicating that PTBP1 is 
necessary for cell proliferation in other systems but the basis for the reported effects was not 
clear. However, the requirement for PTBP1 in proliferation is not universal as the 
proliferation of Ptbp1-deficient early-Pre B cells was normal. This difference could reflect 
compensatory mechanisms or the distinct environments of the GC compared to the bone 
marrow39,40.
PTBP1 controls gene expression by regulating multiple processes in the biogenesis and fate 
of mRNA. The mRNA abundance or AS of 213 genes that are part of the c-MYC-dependent 
gene expression program induced upon positive selection was PTBP1-dependent, but there 
are additional direct and indirect targets of PTBP1 that are not part of the MYC-dependent 
program. Amongst these, we observed changes in AS of Sema4d, Pdlim7, Pbrm1, Acly and 
Ikzf3. Changes in Semaphorin 4d (CD100, Sema4d) could affect the migration of GC B 
cells through the LZ and DZ and interactions with T cells41. Changes in enigma (Pdlim7) 
could alter p53 expression42. Altered splicing of ATP citrate lyase (Acly) could have an 
impact on lipid biosynthesis43. Polybromo-1 (Pbrm1 or BAF180) is part of the SWI/SNF-B 
(PBAF) chromatin-remodelling complex and a c-MYC cofactor which could help propagate 
the c-MYC-induced gene expression program44 and alterations in Aiolos (Ikzf3) might 
influence plasma cell formation45. Despite the potential for these genes to have roles in GC 
B cell biology most of the alternative isoforms found have not been studied before. 
Elucidation of the functions of these AS transcripts in GC B cell biology will require careful 
examination.
Pkm and Tyms are but two examples of c-MYC regulated genes that are subject to PTBP1-
dependent AS. TYMS inhibition by 5-flurouracil blocks primary T cell46 and B cell 
proliferation in vitro (data not shown). Splicing of the retained intron upstream of exon 2 
from the full-length Tyms transcript is necessary for increased Tyms mRNA expression in 
cultured cells47. Reduced amounts of TYMS could be one limiting factor for the 
proliferation of positively selected GC B cells. Other PTBP1 regulated events must also 
promote GC B cell proliferation and our results implicate the regulation of PKM activity as 
important for B cell proliferation. PTBP1, by regulating Pkm AS, may limit glycolytic flux 
and thereby contribute to biosynthetic pathways through the accumulation of glycolytic 
intermediates36. Consistent with this, PKM1 expression is growth inhibitory when 
expressed in cancer xenograft tumour models36 and B cell proliferation in vitro was 
inhibited by PKM2 activators.
Previous studies reported a function of PTBP2 in antibody class switch recombination 
(CSR)48. We did not detect PTBP2 expression in GC B cells unless Ptbp1 is deleted, and 
antigen-specific IgG1 secretion was unaffected in mice with Ptbp2-deficient B cells. 
Therefore it is unlikely that PTBP2 promotes CSR in GC B cells. Nonetheless, the increase 
in the frequency of IgG1+ GC B cells in Ptbp1-deficient GC B cells could indicate that, if 
expressed, PTBP2 might indeed promote antibody CSR.
There may be additional PTBP1-mediated post-transcriptional processes of importance to 
the GC reaction. Changes in alternative polyadenylation (APA) analysed with DaPars found 
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that Ptbp1 deletion affected the APA of 4 genes in LZ and 7 genes in DZ B cells (Data not 
shown), suggesting a limited role of PTBP1 in regulating APA in GC B cells compared to its 
roles controlling AS and mRNA abundance. However, to fully address the roles of PTBP1 in 
APA analysis of RNAseq libraries specifically targeted at capturing 3’-ends are required. In 
the present study we were unable to measure the impact of PTBP1 on the tempo of 
translation, e.g. through IRES-mediated regulation, within GC B cells and this must await 
improved techniques for measuring translational regulation in rare cell populations.
In summary, we have observed that the regulation of gene expression in B cells by PTBP1 is 
necessary for GC B cell proliferation. At the cellular level PTBP1 functions in GC B cells to 
promote the rapid progression through the late S-phase of the cell cycle. At the molecular 
level we have identified the role of PTBP1 in regulating the quantitative and qualitative 
changes in the transcriptome that are part of the c-MYC-dependent gene expression 
program. Post-transcriptional regulation by PTBP1 acts in concert with transcription factors 
such as c-MYC to integrate anabolic metabolism and cell cycle progression and drive the 
production of high affinity antibodies.
Online Methods
Mice
All mice were on a C57BL/6 background. For bone marrow chimera experiments, B6.SJL 
were used as recipients. Conditional knockout mice used in this study derive from crossing 
the following transgenic strains: Ptbp1fl/fl (Ptbp1tm1Msol)30, Ptbp2fl/fl (Ptbp2tm1.1Dblk)50, 
Cd79acre(Cd79atm1(cre)Reth)51 and AicdaTg-cre (Tg(Aicda-cre)9Mbu)52 as specified in the 
results section. GFP-c-MYC reporter mice Myctm1Slek53 and Rag2-/- knockout mice 
(Rag2tm1Fwa)54 were also used in this study.
Rats
RT7b rats were used for the generation of anti-PTBP3 monoclonal antibodies.
Immunisation Protocols and in vivo BrdU administration
All procedures performed were approved by the Babraham Institute's Animal Welfare and 
Experimentation Committee and the UK Home Office and are in compliance with all 
relevant ethical regulations. Mice immunised with alum-NP-KLH received 100 μg NP-KLH 
(Biosearch Technologies) intraperitoneally (ip). Mice immunised with SRBCs received 
2*108 SRBCs ip. For in vivo BrdU incorporation experiments mice received 2 mg BrdU ip 
1.5 hours before they were culled. Bone marrow competitive chimeras were generated by 
reconstituting lethally irradiated (2 x 500Rad) B6.SJL mice with 3*106 bone marrow cells 
derived from B6.SJL in a 1:1 ratio with CD79acre/+Ptbp1fl/fl cKO or CD79a+/+Ptbp1fl/fl 
control bone marrow cells administered intravenously. Rag2-/- knockout bone marrow 
chimeras were generated by reconstituting sub-lethally irradiated (1x 500Rad) Rag2-/- 
knockout mice with 3*106 bone marrow cells from Cd79a+/+ Ptbp1fl/flMycGFP/GFP or 
Cd79acre/+Ptbp1fl/flMycGFP/GFP mice administered intravenously. Mice used in 
immunisation experiments with different genotypes were sex and age matched. Whenever 
possible littermates of the same sex but different genotypes were kept in the same cages to 
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avoid confounding effects. Male and female mice were used in this study. Except in bone 
marrow reconstitution experiments, immunisations were carried out on 8 to 14 week-old 
mice. Bone marrow competitive chimeras were immunised 15 weeks post reconstitution. 
Rag2-/- knockout bone marrow chimeras were immunised 13 weeks post reconstitution.
Flow cytometry
Single cell suspensions were prepared from tissues by passing the tissues though cell 
strainers with 70 and 40 μm pore sizes. After Fc receptors (CD16/32) were blocked with the 
monoclonal rat antibody 2.4G2 cells were stained with different antibodies listed in 
Supplementary Table 6 table in 1% FCS PBS at 4 °C. Cell viability was assessed by staining 
cells with the Fixable Viability Dye eFluor® 780 dye from eBioscience. Unless otherwise 
stated, dead cells were always excluded from the analysis. For intracellular staining cells 
were fixed and permeabilized with the BD Cytofix/Cytoperm™ Fixation and 
Permeabilization Solution from BD Biosciences. Nuclear permeabilization was carried out 
with the Permeabilization Buffer Plus from BD Biosciences when cells were prepared from 
the spleen or by freezing fixed cells in FCS containing 10% DMSO at -80 °C when cells 
were isolated from the bone marrow. Intracellular staining was carried out by incubating 
permeabilized cells with combinations of antibodies (listed in Supplementary Table 6) 
diluted in BD Perm/Wash Buffer. For some intracellular stains such as for those detecting 
PTBP1, the incubation with antibodies was carried out for 4 hours at room temperature. 
Foxp3/Transcription Factor Staining Buffer Set from eBioscience was also occasionally 
used. BrdU and DNA stainings were carried out using the FITC BrdU Flow Kit from BD 
Biosciences. Anti PTBP1, PTBP2 and PTBP3 monoclonal antibodies were directly 
conjugated using Alexa Fluor® 488, Alexa Fluor® 647 or Pacific Blue Antibody Labeling 
Kits from ThermoFisher Scientific.
Detection of NP specific immunoglobulins
NP-specific antibodies of different affinities were detected as previously described14 using 
two different conjugation ratios of NP to BSA. Detection of NP-specific antibodies with low 
and high affinity was done by coating ELISA plates with a ratio of at least 20 NP per 1 BSA 
molecule (NP20, Biosearch Technologies). Detection of NP-specific antibodies with only 
high affinity was performed by coating ELISA plates with a ratio of 2 NP per 1 BSA 
molecules. End-point titres were calculated from serial dilutions of serum samples.
Isolation of B cells and ex vivo stimulation
B cells were isolated from spleens of mice after preparing a single cell suspension by MACS 
negative depletion with a B cell isolation kit (Cat. # 130-090-862 from Miltenyi). When 
stimulated ex vivo B cells were cultured in IMDM media (Cat # 21980, ThermoFisher 
Scientific) with L-Glutamine and 25mM HEPES, supplemented with 10% heat inactivated 
FCS, 50 μM β-Mercaptoethanol, penicillin and streptomycin (GIBCO). Cells were 
stimulated with LPS (10 μg/ml 127:B0, Sigma); anti-CD40 antibody (FGK4.2, 10 μg/ml), 
IL-4 (10 ng/ml) and IL-5 (10 ng/ml) or anti-IgM antibody (B7.6, 9 μg/ml) and IL-4 (10 ng/
ml). In proliferation assays B cells were labeled with CellTrace™ Violet (ThermoFisher) 
before culturing them. 1.5*105 B cells were added per well in 96 well plates. Cells were 
counted using counting beads analysed by flow cytometry. In PKM stimulation experiments 
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DASA-5855 (MedChem Express, Cat. # HY-19330-1ml) was added to the cultures. The 
same amount of DMSO as the highest concentration of DASA-58 was added to the cultures 
as vehicle control.
PTBP1 iCLIP
iCLIP reveals the site of direct binding of a RBP to RNA at single nucleotide resolution. 
This is achieved first by the covalent binding of the RBP to its cognate RNA in intact cells 
by UV irradiation and second, through the truncation of cDNA synthesis when reverse 
polymerase encounters residual peptides derived from the RBP at the site of cross-linking to 
the RNA56. PTBP1 immunoprecipitations were carried out with the CLONE 1 monoclonal 
antibody (ThermoFisher Scientific, Cat. # 32-4800) coupled to protein A/G magnetic beads 
(Pierce, Cat. #88802) and UV-cross-linked (150mJ/cm2) cell extracts of primary B cells 
stimulated ex vivo for 48h with LPS as described above. B cells were isolated from several 
C57BL/6 females and pooled together before stimulation. 30*106 cells were used in each 
immunoprecipitation and were lysed in 50 mM Tris-HCL pH7.4, 100mM NaCl, 1% NP-40 
and 0.1% SDS lysis buffer. Before immunoprecipitating PTBP1, cell extracts were treated 
with Turbo DNAse (Ambion, #AM2239) and low amounts of RNAse I (1.5 to 3 units) from 
Ambion (Cat. # AM2294). Immunoprecipitates were run on a SDS-PAGE and RNA-protein 
complexes were transferred to a nitrocellulose membrane. Protein-RNA complexes were 
isolated from the nitrocellulose membrane after cutting only the areas (from ~75 to ~120 
kDa) where PTBP1 was expected to be cross-linked to long RNAs. After protein digestion, 
RNA was isolated and cDNA synthetized by reverse transcription. At this time barcoded 
primers were used which allow first, the identification of cDNAs generated from the same 
RNA molecule (with a random unknown 4 nucleotide barcode) which allows to discriminate 
PCR duplicates and second, multiplexing of several samples together. Amplification of 
iCLIP cDNA libraries was done with 20 to 27 PCR cycles. We carried out five replicates. 
Multiplexed iCLIP cDNA libraries were sequenced on an Illumina HiSeq 2000 platform on 
a 50 bp single-ended mode. Negative controls (PTBP1 immunoprecipitations from non-UV 
cross-linked lysates and immunoprecipitations with a mouse IgG1 negative isotype control 
antibody) resulted in very little isolated RNA, from which no cDNA library could be 
generated.
Computational processing of iCLIP data
Identification of transcriptome-wide PTBP1 binding sites was done as previously 
described56. Briefly, mapping of cDNAs to the mouse genome (mm10) was carried out with 
Bowtie and those reads that mapped to the same location and had the same random 4 nt 
barcode were considered PCR duplicates and collapsed as a single cDNA molecule. A 
PTBP1 binding site (or X-link site) is the nucleotide before the first nucleotide of a mapped 
cDNA molecule. A FDR value, which determines the probability of a X-link site to appear 
by chance, was calculated (as described in56) for each X-link site. iCLIP is highly 
dependent on RNA abundance and therefore, is not an absolute measurement of RNA-
protein interactions. For this reason we pooled the five replicates together before calculating 
FDRs for each X-link site.
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Generation of mRNAseq libraries
LZ and DZ GC B cells from CD79acre/+Ptbp1fl/fl cKO or CD79a+/+Ptbp1fl/fl control mice 
were FACS-sorted from animals immunised with alum-NP-KLH seven days before. Single 
cell suspensions were prepared from spleens of immunised mice. Erythrocytes were lysed 
and GC B cells were enriched before FACS sorting by depleting cells stained with 
biotinylated anti IgD, CD3e, Gr1 and Ter119 antibodies by MACS. Four biological 
replicates were used per condition. In each biological replicate, GC B cell-enriched 
splenocytes from 3 to 5 animals of the same genotype and sex were pooled together before 
FACS sorting. LZ and DZ GC B cells were sorted from the same GC B cell enriched 
samples. LZ and DZ GC B cells from control CD79a+/+Ptbp1fl/fl and CD79acre/+Ptbp1fl/fl 
cKO mice were sorted on the same day. Two biological replicates per condition were from 
females and two from males.
RNA was prepared using the RNeasy Micro Kit kit from Qiagen (Cat. #74004) from 
~25.000 up to ~200.000 cells. RNA quality was analysed on a 2100 Bioanalyzer (Agilent). 
RNA integrity numbers ranged from 9.1 to 10. 2 ng of total RNA was used to generate 
cDNA from polyadenylated transcripts using the SMART-Seq v4 Ultra low input RNA kit 
from Clontech (Cat. #634888). cDNA quality was analysed on a 2100 Bioanalyzer (Agilent). 
0.5 ng cDNA were used to prepare the mRNAseq libraries with 8 cycles of PCR using the 
Ultra Low library preparation kit v2 from Clontech (Cat. #634899). Compatible barcoded 
libraries were multiplexed and sequenced across three lanes on an Illumina HiSeq 2500 
platform on a 100bp paired-end mode.
Analysis of mRNAseq libraries generated in this study
Trimming of libraries was carried out with Trimgalore (v0.4.2) using default parameters. 
After that, reads were mapped to the mouse Mus_musculus.GRCm38 genome with Hisat257 
using -p 7 -t --phred33-quals --no-mixed --no-discordant parameters and providing a known 
splice sites file generated from the Mus_musculus.GRCm38.70.gtf annotation. Counting of 
reads mapping to all exons of a particular gene was done with HTSeq58 using the 
Mus_musculus.GRCm38.84.gtf annotation and default parameters. DESeq2 (v1.12.1)59 was 
used to calculate differential RNA abundance between two conditions at the whole gene 
level by quantifying differences in RNA complementary to all annotated exons of a 
particular gene in the RNAseq data. Information on the genotype and sex of the animals was 
included in the design formula in order to control for variation in the data due to the sex 
differences in the samples. DESeq2 results were only considered for genes that are 
expressed with at least 1 FPKM in any of the conditions. Significant differentially abundant 
genes are those that have an adjusted p-value <0.1.
Differential alternative splicing (AS) was analysed with rMATS (v3.2.2)60. rMATS uses an 
exon-centric approach to discover both annotated and unannotated AS events in a reference 
transcriptome. To compare changes in AS between two conditions rMATS calculates first 
inclusion levels (defined as the proportion of transcripts containing that particular AS 
segment) for five different types of AS events: skipped exons (SE), mutually exclusive exons 
(MXE), alternative 5’ splice sites (A5SS) alternative 3’ splice sites (A3SS) and retained 
introns in each of the two conditions (Supplementary Fig. 4e). Subsequently, rMATS 
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calculates inclusion level differences by subtracting the inclusion levels of condition one 
from the inclusion levels of condition two (see Supplementary Fig. 4f). The version used of 
rMATS only accepts mapped reads of a particular length. For this reason, libraries trimmed 
with Trimgalore as described above were further trimmed with Trimmomatic v0.3561 so that 
all reads had a length of 98 bp. Reads shorter than 98 bp were discarded. These reads of only 
98bp were then mapped to the mouse genome using Hisat2 as described above. rMATS was 
run on a paired mode (-analysis P) to analyse differential AS between two conditions using 
the Mus_musculus.GRCm38.84.gtf annotation. Only results obtained with reads that map to 
exon-exon junctions were used for further analysis. Genes that have less than 1 FPKM in the 
analysed conditions were discarded. Significantly differentially spliced events are those that 
have an FDR <0.05. A cut-off of an inclusion level difference greater than 10% (0.1) was 
introduced for significant differentially alternatively spliced events.
We assigned PTBP1 binding to the vicinity of a differentially alternatively spliced event if 
we found at least a significant PTBP1 binding site in our iCLIP data in the following cases. 
Skipped exons (SE) were considered to be bound by PTBP1 if a binding site was identified 
on the SE, on the intronic 500 nucleotides upstream and downstream of the SE 3’ splice site 
(SS) and 5’SS, respectively; on the upstream flanking constitutive exon and the intronic 500 
nucleotides downstream of its 5’SS or on the downstream flanking constitutive exon and the 
intronic 500 nucleotides upstream of its 3’SS. Mutually exclusive exons (MXE) were bound 
by PTBP1 if a binding site was found on any of the MXE and the intronic 500 nucleotides 
upstream and downstream of their 3’SS and 5’SS, respectively; on the upstream flanking 
constitutive and the intronic 500 nucleotides downstream of its 5’SS or on the downstream 
flanking constitutive exon and the intronic 500 nucleotides upstream of its 3’SS. Alternative 
5’ splice sites (A5SS) were bound by PTBP1 if a binding site was found on the longer exon 
generated by the A5SS, the intronic 500 nucleotides downstream of the 5SS of the longest 
A5SS exon or on the flanking constitutive exon downstream of the A5SS and the intronic 
500 nucleotides upstream of its 3SS. Alternative 3’ splice sites (A3SS) were bound by 
PTBP1 if a binding site was found on the longer exon generated by the A3SS, the intronic 
500 nucleotides upstream of the 3SS of the longest A3SS exon or on the flanking 
constitutive exon upstream of the A3SS and the intronic 500 nucleotides downstream of its 
5SS. A retained intron was bound by PTBP1 if a binding site was found on the exon 
resulting from intron retention.
Differential alternative polyadenylation site usage
Alternative polyadenylation (APA) usage was assessed with the 'Dynamic analysis of 
Alternative PolyAdenylation from RNA-Seq' algorithm (DaPars v0.9.162). DaPars computes 
first the Percentage of Distal polyadenylation (polyA) site Usage Index (PDUI) and, 
subsequently, computes changes in PDUI between two conditions (ΔPDUI). Annotated gene 
models were generated from mouse genome build GRCm38/mm10, facilitating the 
prediction of proximal de novo APA sites as well as long and short 3′ UTR expression 
levels. Bedtools v2.25.0 was used to convert the RNA-seq BAM files to BedGraph format, 
and these files were then used as input for DaPars to identify dynamic APA usage between 
the control and knockout mice. Differences in APA were considered for those genes with an 
absolute change in percentage of distal polyA site usage of >20% (ΔPDUI >|0.2|), an 
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adjusted P-value of <0.05 and a fitted value of the regression model used to identify the 
proximal polyA site > 500.
Analysis of mRNAseq libraries previously published
RNAseq data from Hogenbirk et al.49 was trimmed with Trimgalore (v0.3.8) using default 
parameters. Trimmed reads were mapped to the mouse genome using Tophat2(v2.0.12)63 
with -p 6 -g 2 parameters and the Mus_musculus.GRCm38.70.gtf annotation. Mapped reads 
to exons of a particular gene were counted with HTSeq58 using the 
Mus_musculus.GRCm38.73.gtf annotation and default parameters. Differential RNA 
abundance was calculated with DESeq2 (v1.4.5).
RNAseq data generated by Gitlin et al.3 was trimmed with Trimgalore (v0.4.1). Trimmed 
reads were mapped to the mouse genome with Tophat2 (v2.0.12)63 with -p 6 -g 2 
parameters and the Mus_musculus.GRCm38.70.gtf annotation. Mapped reads were counted 
with HTSeq using the Mus_musculus.GRCm38.75.gtf annotation and default parameters. 
DESeq2 (v1.8.1) was used to analyse differential RNA abundance between GC B cells that 
received high levels of T cell help (Anti-DEC-OVA) and GC B cells that did not receive high 
levels of T cell help (Anti-DEC-Ctrl). Genes with a p-adjusted value <0.05 were considered 
to have significant differential RNA abundance. Genes with a positive log2 fold change 
(Anti-DEC-OVA vs Anti-DEC-Ctrl) were chosen as genes that are increased in GC B cells 
receiving high levels of T cell help compared to GC B cells that are not receiving high levels 
of T cell help (used in Fig. 5).
RNAseq data published by Chou and colleagues7 was trimmed with Trimgalore 
(v0.4.2_dev). Trimmed reads were mapped to the mouse genome using Hisat2(v2.0.5)57 and 
the Mus_musculus.GRCm38 genome. Reads mapping to all exons of a particular gene were 
counted with HTSeq using the Mus_musculus.GRCm38.84.gtf annotation and default 
parameters. Differential RNA abundance between two conditions was calculated with 
DESeq2 v1.12.4. Genes with an increased RNA abundance in AP4+Myc+ LZ GC B cells 
compared to AP4-Myc- LZ GC B cells used in Fig. 5 were defined as genes with a p-
adjusted value <0.05 whose log2 fold change (AP4+ Myc+ LZ GC B cells vs AP4- Myc- LZ 
GC B cells) is equal or greater than 1.5.
Calculation of FPKMs
FPKMs (Fragments per kilobase of exon per million reads mapped) were used to compare 
expression values of different genes or transcripts and to filter genes based on their 
expression level. FPKMs were calculated with the Cuffnorm option of Cufflinks (v2.2.1)64 
using the geometric normalisation method and the mapped reads of the different RNAseq 
libraries described above. The following annotations were used to calculate FPKMS from 
the different studies: Mus_musculus.GRCm38.84.gtf was used with our RNAseq data and 
data from Chou et al.7, Mus_musculus.GRCm38.83.gtf was used with the data from 
Hogenbirk et al.49 and Mus_musculus.GRCm38.75.gtf was used with data published by 
Gitlin et al.3.
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GO analysis
Gene ontology terms enrichment analysis was carried out with GOrilla65. A background list 
of genes (genes which were expressed with at least 1 FPKM in the conditions analysed) was 
included in the analysis. For visualisation purposes when several related terms were 
significantly enriched the term which had a higher percentage of significant genes with 
different mRNA abundance or AS was chosen to be shown in Supplementary Fig. 5.
RNAseq data visualisation
Sashimi plots, which show RNAseq coverage and reads mapping across exon-exon junctions 
were generated using the IGV genome browser.
Analysis of Jh4 mutations
Mutations in the Jh4 intronic region were analysed as previously described4. Briefly, 
genomic DNA was isolated from FACS-sorted GC B cells from spleens of mice that were 
immunised with alum-NP-KLH 7 days before. GC B cells from 2 to 4 mice of the same 
genotype and sex were pooled together. Jh4 intronic regions were amplified with the primers 
Jh4-intron Forward and Jh4-intron Reverse in using the PfuUltra II Fusion HS DNA 
Polymerase (Agilent Technologies) in a PCR with 35 cycles, 57 °C annealing temperature 
and 15 seconds extension time at 72 °C. PCR amplified Jh4 intronic regions were cloned 
using the Zero Blunt® TOPO® PCR Cloning Kit (ThermoFischer scientific). Mutation 
frequencies were calculated by dividing the total number of mutations identified in each 
replicate by the total length of amplified DNA (565 bp per clone analysed, which is the 
genomic region amplified by PCR without taking into account the regions complementary to 
the primers).
Generation of anti PTBP3 mAb
RT7b rats were immunised with a GST-PTBP3 fusion protein containing amino acids 279 to 
359 of the full-length mouse PTBP3 generated in E. coli. After several immunisations 
spleens were isolated and fused to the IR983F rat myeloma cell line. Hybridomas were 
screened by immunoblot using HEKT cell lysates expressing mouse PTBP3, PTBP1 or 
PTBP2-GFP fusion proteins. Two hybridomas secreted IgG2a antibodies specific for 
PTBP3: MAC454 and MAC455. Monoclonal antibodies secreted by these two hybridomas 
were purified by affinity chromatography using protein G.
Immunoblot
In order to analyse PKM1 and PKM2 expression, 12 μg of proteins extracted from B cells 
isolated as described above from individual mice and stimulated or not with LPS for 48h 
were run on a 10% SDS-PAGE and transferred to a nitrocellulose membrane. PKM1 
detection was carried out with a rabbit monoclonal antibody (clone D30G6, Cell Signalling) 
and PKM2 was detected with a rabbit monoclonal antibody (clone D78A4, Cell signalling). 
Visualisation of anti PKM1 and PKM2 antibodies was carried out with an HRP-conjugated 
goat anti-rabbit antibody (Cat # 2020-10, Dako). Immunoblot analysis of the different 
PTBPs was carried out with 15 μg of proteins extracted from B cells isolated as described 
above from individual mice run on a 10 % SDS-PAGE and transferred to a nitrocellulose 
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membrane. Mouse monoclonal primary antibodies were detected with an anti-mouse 
TrueBlot HRP-conjugated antibody (eBioscience, Cat. #18-8817-31). Rat monoclonal 
primary antibodies were detected with anti-rat goat HRP-conjugated antibodies (Cat. 
#P0450, Dako). Rabbit primary antibodies were detected with HRP-conjugated goat anti-
rabbit antibody (Cat. #2020-10, Dako).
Quantification and statistical analysis
Flow cytometry data was analysed using FlowJo (versions 10.0.8r1 or 9.8.3). Analysis and 
quantification of RNAseq and iCLIP experiments is detailed in the methods detail section. 
Statistical significance of flow cytometry data was assessed using Prism (versions 7 or 6). 
The details of the tests used in different experiments can be found in the figure legends).
Data availability
mRNAseq and iCLIP data that support the findings of this study have been deposited in 
GEO with the GSE100969 accession code.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. PTBP1 expression is increased in positively selected GC B cells.
(a) Ptbp1 and Ptbp3 mRNAseq normalised DESeq2 read counts in sorted GC B cell 
populations by c-MYC and AP4 expression7. P***<0.001, P*<0.05 and ns (non-significant) 
P >0.1. P-adjusted values were calculated with DESeq2 for the comparisons indicated by the 
horizontal lines
(b) Gating strategy for GC and non-GC B cells and expression of different PTBPs within the 
gated populations analysed by flow cytometry 7 days after NP-KLH immunisation. Full 
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gating strategy is shown in Supplementary Fig. 1e. Data shown is representative from three 
independent experiments.
(c) Flow cytometry analysis of PTBP1 and PTBP3 in GFP-c-MYC+ and GFP-c-MYC- GC B 
cells from MycGFP/GFP mice immunised with SRBC for 6 days. Cytometry plot shows 
CXCR4 and CD86 expression of GFP-c-MYC+ (dots) and GFP-c-MYC- (density plot) GC 
B cells.
In b and c, graphs show geometric mean fluorescence intensity (gMFI) for each anti-PTBP 
antibody after subtraction of background staining determined with isotype control antibodies 
as shown in Supplementary Fig. 1f. Each symbol shows data from an individual mouse and 
bars represent the mean. Two-tailed paired Student’s t-test. ns (not significant) P>0.1, 
**P<0.01 and ***P<0.001. Numbers in cytometry plots show percentages of the gated 
populations.
Monzón-Casanova et al. Page 22
Nat Immunol. Author manuscript; available in PMC 2018 July 22.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2. PTBP1 is necessary for GC B cell responses.
(a) Representative flow cytometry plots showing gating strategy for GC B cells, DZ and LZ 
GC B cells from the spleen of mice immunised with NP-KLH for 7 days. Events shown on 
the left have been pre-gated on B220+CD19+ cells. Numbers indicate the percentages of the 
gated populations.
(b) Percentages and numbers of GC B cells, DZ and LZ GC B cells identified as shown in a. 
Data shown is representative of more than four independent experiments. Bar graphs show 
data from individual mice from one experiment and the mean is depicted with the bar. ns 
P>0.05, *P<0.05, **P<0.01 from two-tailed unpaired Student’s t-test are shown for the 
indicated comparisons.
(c) Anti-NP20 (high + low affinity) or anti-NP2 (high affinity only) IgG1 end-point titers 
measured by ELISA in the sera of mice at different days following immunization with NP-
KLH.
(d) High affinity (NP2) vs. high and low affinity (NP20) anti-NP IgG1 ratio calculated from 
the data shown in c. Data in c and d are from one out of two independent experiments with 
similar results. The experiment shown had 3 Cd79a+/+Ptbp1fl/fl control mice and 6 
Cd79acre/+Ptbp1fl/fl cKO mice. Shown is the mean + SD in c and ± SD in d. Differences 
between control and cKO mice were analysed with two-way ANOVA plus Sidak’s multiple 
comparison test. ns P>0.05, *P≤0.05 and ***P≤0.0002.
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Figure 3. PTBP2 is partially redundant with PTBP1 in GC B cells.
(a) Representative flow cytometry plots showing gating strategy of for GC B cells, DZ and 
LZ GC B cells following SRBC immunisation (day 8). Events shown on the left have been 
pre-gated on CD19+ cells. Numbers indicate the percentages of the gated populations.
(b) Percentages and numbers of GC B cells, DZ GC B cells and LZ GC B cells identified as 
shown in a from spleens of mice after immunisation with SRBC (day 8). Bar graphs show 
data from individual mice and the mean is depicted with the bar. **P<0.01, ***P<0.001 
from two-tailed unpaired Student’s t-test are shown for the indicated comparisons. Data in a 
and b is representative from two independent experiments.
Monzón-Casanova et al. Page 24
Nat Immunol. Author manuscript; available in PMC 2018 July 22.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
(c) PTBP1, PTBP2 and PTBP3 expression in GC B cells (CD95+CD38lowCD19+) from 
spleens of mice 8 days post SRBC immunisation. Numbers shown in plots are the 
percentages of cells within the gates.
(d) Geometric mean fluorescence intensity of PTBP1 analysed by flow cytometry in GC B 
cells shown in c. Each symbol represents data from a different mouse. **P<0.01, 
***P<0.001 from unpaired two-tailed Student’s t-test are shown for the comparisons 
indicated.
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Figure 4. PTBP1 regulates mRNA abundance and AS in GC B cells.
(a) MA plot comparing changes in mRNA abundance at the gene level when comparing LZ 
to DZ GC B cells in Cd79a+/+Ptbp1fl/fl (Controls) or Cd79acre/+Ptbp1fl/fl (P1 cKO) mice.
(b) MA plot comparing changes in mRNA abundance at the gene level in LZ and DZ GC B 
cells from Cd79a+/+Ptbp1fl/fl (Ctrl) and Cd79acre/+Ptbp1fl/fl (P1 cKO) mice.
In a and b genes with significant (padj value < 0.1) different mRNA abundance and 
expressed with at least 1 fragments per kilobase of exon per million reads mapped (FPKM) 
in one of the conditions analysed are shown in red, genes with a padj value ≥0.1 are shown 
in dark grey. The number of significantly changed genes are given in the right-hand corners 
of each plot.
(c) Changes in AS when comparing LZ to DZ GC B cells in controls (Cd79a+/+Ptbp1fl/fl) 
and P1 cKO (Cd79acre/+Ptbp1fl/fl) cells for skipped exons (SE), mutually exclusive exons 
(MXE), alternative 5’ and 3’ splice sites (A5SS and A3SS, respectively) and retained introns 
(RI) (Supplementary Fig. 4e).
(d) Changes in AS due to Ptbp1 deletion in LZ and DZ GC B cells. Ctrl: Cd79a+/+Ptbp1fl/fl 
and P1 cKO: Cd79acre/+Ptbp1fl/fl.
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c and d show inclusion level differences of significantly (FDR <0.05) differentially AS 
events with an inclusion level difference bigger than 10% (≥0.1 or ≤-0.1) for the 
comparisons made. Supplementary Fig. 4f shows an example of inclusion level difference 
calculation. Numbers in the graphs show the number of events that are differentially 
alternatively spliced.
(e) Overlaps of the number of genes with different mRNA abundance (a,b) and different AS 
(at any of the event types shown in c,d).
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Figure 5. Positive selection gene expression program is reduced due to Ptbp1 deletion.
(a) Genes which have different mRNA abundance (DA) in LZ GC B cells due to Ptbp1 
deletion which are c-MYC targets (GSEA HALLMARK_MYC_TARGETS_V1), increased 
in GC B cells receiving high levels of T cell help compared to CG B cells which do not 
receive high levels of T cell help and increased in c-MYC+AP4+ LZ GC B cells compared to 
c-MYC-AP4- LZ GC B cells. DS means differentially AS (inclusion level difference >10%). 
Numbers in the MA plots indicate the number of genes that are part of the studied gene sets 
and have DA in LZ GC B cells due to the lack of PTBP1.
(b) Myc and AP4 (Tfap4) mRNAseq data from LZ and DZ GC B cells.
(c) GFP-c-MYC+ GC B cells gating strategy. Events shown correspond to GC B cells 
(CD19+CD38lowCD95high) from spleens of Rag2-/- mice reconstituted with Cd79a+/+ 
Ptbp1fl/flMycGFP/GFP or Cd79acre/+Ptbp1fl/flMycGFP/GFP bone marrow cells 8 days post 
SRBC immunisation.
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(d) Percentages of GFP-c-MYC+ cells within GC B cells and c-MYC gMFI of GFP-c-MYC
+
 GC B cells as shown in c. Dots show data from individual mice. Bars show the means. ns 
P>0.05, *P<0.05 from unpaired two-tailed Student’s t-tests are shown.
(e) Differentially AS events (FDR <0.05) with an inclusion level difference greater than 10% 
due to Ptbp1 deletion in LZ GC B cells from genes that are part of the gene sets shown in a. 
Labels indicate the gene name followed by the type of alternatively spliced event and the 
rMATS id number, which can be found in Supplementary Table 3. Genes bound by PTBP1 
nearby the AS event can be found in Supplementary Table 5.
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Figure 6. Late S-phase progression is impaired in the absence of PTBP1.
(a) Gating strategy for GC B cells (B220+CD19+CD38lowCD95high) at different stages of 
the cell cycle based on BrdU and DNA (7AAD) staining by flow cytometry in cells from 
spleens 7 days after immunisation with NP-KLH. Numbers shown are percentages.
(b) Percentages of cells in each phase of the cell cycle as shown in a. Individual data points 
represent individual mice. Bars depict the mean. ns P>0.05, *P<0.05 and ***P<0.001 from a 
two-tailed Student’s t-test are shown above the comparisons made. Data shown is 
representative from three independent experiments.
(c) Gating strategy for dead (viability dye eFluor780+) LZ (CD86highCXCR4low) or DZ 
(CD86lowCXCR4high) GC B cells (CD95+CD38lowCD19+B220+) by flow cytometry. 
Numbers are proportions of cells.
(d) Percentages of dead (viability dye eFluor780+) cells shown in c. Data points show data 
from individual mice of one out of three similar independent experiments. Bars depict 
means. ns P>0.05 and *P<0.05 shown are from two-tailed unpaired t-tests. Data shown is 
representative from three independent experiments.
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Figure 7. PTBP1 regulates Tyms mRNA abundance through control of alternative splicing.
(a) Tyms FPKMs in GC B cells compared to naïve B cells49, in GC B cells receiving high 
levels of T cell help (Anti-DEC-Ctrl) compared to CG B cells which do not (Anti-Dec-
OVA)3 or in LZ and DZ B cells which express c-MYC+AP4+ or not7.
(b) Tyms mRNAseq from LZ GC B cells and PTBP1 iCLIP data. Sashimi plots show read 
coverage and the reads that map to exon-exon junctions with arches. The numbers on the 
arches are the number of reads that map to that exon-exon junction. Scale on the PTBP1 
iCLIP track shows the number of independent X-link sites identified.
(c) NMD/FL read ratio of reads mapping to exons and retained introns which will generate a 
NMD Tyms transcript (NMD, yellow bins in b) vs. reads mapping to the first three exons 
needed for the full-length Tyms (FL, blue bins in b) of mRNAseq libraries from GC B cells 
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which receive high levels of T cell help (Anti-Dec-OVA) or not (Anti-DEC-Ctrl)3 and in LZ 
and DZ GC B cells which express c-MYC+AP4+ or not7.
(d) NMD/FL read ratio of mRNAseq libraries from LZ and DZ GC B cells.
(e) Tyms DESeq2 normalised read counts. ***Padj value<0.001 is shown. Not significant 
(ns) Padj>0.1.
(f) TYMS protein levels analysed by flow cytometry in non-GC B cells (CD19+CD95-
CD38high) and LZ (CD86hiCXCR4low) or DZ (CD86lowCXCR4high) GC B 
(CD19+CD95+CD38low) cells from the spleens of mice 8 days after immunisation with 
SRBCs. gMFI of TYMS is shown after subtraction of background staining determined with 
isotype control staining. Student’s two-tailed t-tests. *P<0.05 and ***P<0.001.
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Figure 8. PTBP1 regulates alternative splicing of Pkm.
(a) Pkm1 and Pkm2 transcript levels (FPKMs) calculated with Cuffnorm in GC B cells and 
naïve B cells49, in GC B cells receiving high levels of T cell help (Anti-DEC-Ctrl) and CG 
B cells which do not receive high levels of T cell help (Anti-Dec-OVA)3 or in LZ and DZ 
GC B cells which express c-MYC+AP4+ or not7.
(b) rMATS inclusion values for exon 9 (Pkm1) of Pkm.
(c) Visualisation of mRNAseq and PTBP1 iCLIP data as in Fig. 7b but for Pkm exons 8 
to10.
(d) Immunoblots of PKM1 and PKM2 proteins in B cells freshly isolated from the spleen 
(ex vivo) or stimulated in vitro for 48h with LPS. Protein lysates from B cells isolated from 
different mice (numbers above the plots) are shown. Immunoblot images were cropped. Full 
images can be found in Supplementary Fig. 8.
(e) Pkm1 and Pkm2 transcript levels (FPKMs) calculated with Cuffnorm in our mRNAseq 
libraries from LZ and DZ GC B cells.
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(f) CellTrace Violet profile from in vitro stimulated splenic B cells stimulated for 62 hours 
as indicated above the histogram overlays in the presence of DASA-58 or vehicle control (as 
the highest concentration of DASA-58).
(g) Quantification of the proliferation profiles shown in f and absolute cell numbers 
recovered from the cultures. Each dot shows data from B cells isolated from an individual 
mouse. Bar graphs depict the mean. ns P>0.05, *P<0.05, **P<0.01 and ***P<0.001 from 
unpaired Student’s two-tailed t-tests are shown.
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